Skip to main content
. Author manuscript; available in PMC: 2015 Jul 1.
Published in final edited form as: Psychooncology. 2014 Feb 17;23(7):820–826. doi: 10.1002/pon.3492

Table 3.

Linear regression output for primary analyses.

Fact B total Score

Model Variable b SE p R2change 95% CI

Step 1 Cancer Stage -2.732 1.564 .084 .027 -5.843, .379
Comorbidities -3.221 3.518 .363 .008 -10.218, 3.775
Cardiac Meds -1.577 4.861 .746 .001 -11.243, 8.089
BMI -.576 .296 .055 .033 -1.165, .014
Age .096 .196 .627 .002 -.295, .486
Time Since Tx -.075 .221 .736 .001 -.513, .364
RSA 1.341 2.737 .625 .002 -4.102, 6.783
Anxiety -.568 .208 .008 .063 -.983, -.153
Avoidance -.444 .220 .047 .036 -.881, -.007
F 3.361 .001
df (9,84)
R2 .265

Step 2 Cancer Stage -3.061 1.543 .051 .034 -6.131, .008
Comorbidities -3.096 3.453 .372 .007 -9.963, 3.771
Cardiac Meds -1.810 4.77 .705 .002 -11.298, 7.678
BMI -.601 .291 .042 .036 -1.180, -.022
Age .120 .193 .536 .004 -.264, .504
Time Since Tx -.179 .222 .423 .006 -.621, .263
RSA .853 2.69 .753 .001 -4.509, 6.214
Anxiety -.585 .205 .005 .097 -.993, -.178
Avoidance -.408 .216 .063 .030 -.838, .022
Avoidance × RSA .718 .348 .042 .036 .026, 1.410
F 3.567 .001
df (10, 83)
R2 .301